These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32644127)
21. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection. Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE; Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146 [TBL] [Abstract][Full Text] [Related]
23. Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection. Laurens MB; Billingsley P; Richman A; Eappen AG; Adams M; Li T; Chakravarty S; Gunasekera A; Jacob CG; Sim BK; Edelman R; Plowe CV; Hoffman SL; Lyke KE PLoS One; 2013; 8(7):e68969. PubMed ID: 23874828 [TBL] [Abstract][Full Text] [Related]
24. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge. Talley AK; Healy SA; Finney OC; Murphy SC; Kublin J; Salas CJ; Lundebjerg S; Gilbert P; Van Voorhis WC; Whisler J; Wang R; Ockenhouse CF; Heppner DG; Kappe SH; Duffy PE PLoS One; 2014; 9(11):e109654. PubMed ID: 25405724 [TBL] [Abstract][Full Text] [Related]
25. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515 [TBL] [Abstract][Full Text] [Related]
26. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Llanos-Cuentas A; Casapia M; Chuquiyauri R; Hinojosa JC; Kerr N; Rosario M; Toovey S; Arch RH; Phillips MA; Rozenberg FD; Bath J; Ng CL; Cowell AN; Winzeler EA; Fidock DA; Baker M; Möhrle JJ; Hooft van Huijsduijnen R; Gobeau N; Araeipour N; Andenmatten N; Rückle T; Duparc S Lancet Infect Dis; 2018 Aug; 18(8):874-883. PubMed ID: 29909069 [TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223 [TBL] [Abstract][Full Text] [Related]
30. Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast Asia. Yang H; Wang J; Liu H; Li X; Nie R; Li C; Wang H; Wang Q; Cao Y; Cui L Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987144 [TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa. van der Berg JD; Duvenage CS; Roskell NS; Scott TR Clin Ther; 1999 Apr; 21(4):741-9. PubMed ID: 10363739 [TBL] [Abstract][Full Text] [Related]
32. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048. McCarthy JS; Donini C; Chalon S; Woodford J; Marquart L; Collins KA; Rozenberg FD; Fidock DA; Cherkaoui-Rbati MH; Gobeau N; Möhrle JJ Clin Infect Dis; 2020 Dec; 71(10):e657-e664. PubMed ID: 32239164 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic activity of atovaquone against Plasmodium falciparum in humans. Shapiro TA; Ranasinha CD; Kumar N; Barditch-Crovo P Am J Trop Med Hyg; 1999 May; 60(5):831-6. PubMed ID: 10344660 [TBL] [Abstract][Full Text] [Related]
36. Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study. Chughlay MF; El Gaaloul M; Donini C; Campo B; Berghmans PJ; Lucardie A; Marx MW; Cherkaoui-Rbati MH; Langdon G; Angulo-Barturen I; Viera S; Rosanas-Urgell A; Van Geertruyden JP; Chalon S Am J Trop Med Hyg; 2021 Feb; 104(4):1348-1358. PubMed ID: 33556040 [TBL] [Abstract][Full Text] [Related]
37. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil. Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL Malar J; 2008 Nov; 7():240. PubMed ID: 19021900 [TBL] [Abstract][Full Text] [Related]
38. Assessing drug efficacy against Plasmodium falciparum liver stages in vivo. Flannery EL; Foquet L; Chuenchob V; Fishbaugher M; Billman Z; Navarro MJ; Betz W; Olsen TM; Lee J; Camargo N; Nguyen T; Schafer C; Sack BK; Wilson EM; Saunders J; Bial J; Campo B; Charman SA; Murphy SC; Phillips MA; Kappe SH; Mikolajczak SA JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321371 [TBL] [Abstract][Full Text] [Related]